GlassScriptPhysician profile
Hassan Pervaiz
NPI 1710339817
$643.11
in general payments reported to CMS, 2019-2025
9 companies · $73.19 in 2025
The $73.19 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $92.29 · 2023: $87.15 · 2024: $57.88 · 2025: $73.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173 · Education: $45.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.12 |
| Education | $45.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $200.04 | 2021 | |
| Abiomed | $132.56 | 2021 | |
| Harmony Biosciences LLC | $108.93 | 2022-2025 | Wakix |
| Axsome Therapeutics, INC. | $85.14 | 2024-2025 | Sunosi |
| Abbott Laboratories | $33.54 | 2022-2023 | Amplatzer Amulet |
| Teva Pharmaceuticals USA, INC. | $26.43 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.41 | 2023 | Lifevest |
| Boston Scientific Corporation | $18.35 | 2022 | |
| Indivior INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Pervaiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.